发明名称 |
Treatment of Muscular Conditions and Muscular Dystrophies |
摘要 |
The present invention provides methods for improving muscular function or treating a muscular disorder in an individual by administering to the individual a pharmacologically effective amount of a compound that inhibits microtubule-dependent NADPH Oxidase 2 reactive oxygen species signaling production. In addition compounds that block sarcolemmal Ca2+ channel activation and/or renin-angiotensin signaling may be administered with the inhibitor of microtubule-dependent NADPH Oxidase 2 reactive oxygen species signaling production. |
申请公布号 |
US2014256644(A1) |
申请公布日期 |
2014.09.11 |
申请号 |
US201414284736 |
申请日期 |
2014.05.22 |
申请人 |
Ward Christopher W.;Khairallah Ramzi |
发明人 |
Ward Christopher W.;Khairallah Ramzi |
分类号 |
A61K38/17;A61K31/12;A61K31/4178;A61K31/165 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of improving muscular function in an individual, comprising the step of:
administering to said individual a pharmacologically effective amount of a compound that inhibits microtubule-dependent NADPH Oxidase 2 reactive oxygen species signaling production, wherein reduction in microtubule-dependent NADPH Oxidase 2 reactive oxygen species signaling production improves muscular function in said individual. |
地址 |
Baltimore MD US |